ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease […]
In addition to improving treatments and finding a cure for celiac disease, iCureCeliac® is helping researchers appreciate the realities of living with celiac disease, helping to influencing what they choose to research and why.
To cure celiac disease we must fundamentally shift how celiac disease research is conceptualized and conducted. Why? Because the current research paradigm for celiac disease, one that has existed for four decades, has not delivered a cure. Not only has it not delivered a cure, celiac disease research has produced only a single approved treatment […]
With more than 1,200 participants registered in its first four months, iCureCeliac™ is shaping the type of research that is most important to you – the patient. We are pleased to present a few initial findings.
Celiac Disease Foundation is proud to announce the establishment of the CDF Research Committee, chaired by Daniel Adelman, MD, with members Sonia Kupfer, MD, Benjamin Lebwohl, MD, and Fernando Velayos, MD. Committee members will select two representatives from CDF’s Patient Engagement Celiac Disease Network to join them in overseeing CDF’s research-related activities, including iCureCeliac™. Research […]
Celimmune, in partnership with the University of Chicago Celiac Disease Center, and Celiac Disease Foundation have joined forces to deploy the iCureCeliac patient registry as a screen for phase 2 clinical study for refractory celiac disease type II. This is the first-ever use of the new and growing iCureCeliac registry to support celiac disease therapeutic treatment […]
Thank you to our more than 1,000 iCureCeliac participants for your amazing commitment to help researchers advance treatments and a cure for celiac disease and gluten sensitivity. We want to hear your concerns about arsenic in your diet, and give you the opportunity to tell us what studies you think should be done.
In keeping with our mission to advance research by leveraging technology, Celiac Disease Foundation is pleased to announce the February launch of iCureCeliac, a patient-powered research network (PPRN). At iCureCeliac, people living with celiac disease and gluten sensitivity can help facilitate new treatments and a cure by safely and securely contributing their health information online. Patients will also be […]